Publications and Research Notes

KEI publishes research and commentary in a variety of journals, periodicals, books and other independent publishing platforms. In-house, KEI publishes the open journal Knowledge Ecology Studies, and presents information in blogs, correspondence and reports, as well as in occasional KEI research notes and papers.

Timelines

(several) Timelines regarding privileges (such as patents or copyrights) for the commericalization and use of knowledge

KEI Policy Briefs

2014:1 Non­voluntary use of patents for drugs to treat the Hepatitis C Virus in the United States: Mechanisms available to the Federal Government, State Governments and Private Actors. July 18, 2014

2011:1 White House and European Commission trade official oppose waiver of drug patents for Least Developed Countries (LDCs).

KEI Research Notes

2014:1 KEI Research Note: Recent European Union Compulsory Licenses. March 1, 2014

2014:2 KEI Research Note: Recent United States Compulsory Licenses March 7, 2014

2011:2 Tedmund Wan. Survey of drug prices for 14 drugs with US government rights in patents listed in the FDA Orange Book.
2011:1. Paul Miano. Cancer: Approval, ownership, market structure, and placement on WHO Model Essential Medicines List, for 100 new molecular entities (NMEs) on the NCI alpha list of cancer drugs and vaccines.

2010:5 James Love. Differences in ratio of deaths to new cases for 6 cancer types in 14 WHO regions, with reference to income of region.

2010:4 Anne Mira Guha, Prices for Abbott's Norvir (generic name Ritonavir) as a Standalone Product in 2010.

2010:3 Redfield Ward, Notes on the 2004 to 2009 United States Food and Drug Administration Approval of New Molecular Entities (NMEs).

2010:2 Public and Private Sector Funded Research in Fabry's Disease.

2010:1 James Love, Comments on ACTA Provisions on Injunctions and Damages.

2008:3 Jacqueline Lee, Research and Development Related to dasatinib (Sprycel-tm).

2008:2 An Annotated Bibliography of Scholarly and Technical Articles and Books on Innovation Prizes.

2008:1 Selected Innovation Prizes and Reward Programs.

2007:6 David Serafino. Survey of Patent Pools Demonstrates Variety of Purposes and Management Structures.

2007:5 James Love. Compulsory licensing of copyright under Article 44.2 of the TRIPS, in light of eBay.

2007:4 Judit Rius. Organización Mundial de la Salud -- Grupo de Trabajo Intergubernamental sobre Salud Pública, Innovación y Propiedad Intelectual (IGWG).

2007:3 IGWG Briefing Paper on Patent Pools.

2007:2 James Love. Recent examples of the use of compulsory licenses on patents.

2007:1 Benjamin Krohmal. Prominent Innovation Prizes And Reward Programs . (A newer and much expanded version is available as KEI Research Note 2008:1)

KEI Research Papers

2007:1. James Love and Tim Hubbard The Big Idea: Prizes to Stimulate R&D for New Medicines.

2006:1. Judit Rius Sanjuan, James Love and Robert Weissman, Protection of Pharmaceutical Test Data: A Policy Proposal.